Can Saffron (Crocus sativus) be Effective in the Treatment of Leishmaniasis?

ISSN: 2212-3989 (Online)
ISSN: 1871-5265 (Print)

Volume 17, 3 Issues, 2017

Download PDF Flyer

Infectious Disorders - Drug Targets

Formerly: Current Drug Targets - Infectious Disorders

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Jean-Marc Sabatier
Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique'
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 - MARSEILLE, Cedex 20

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Can Saffron (Crocus sativus) be Effective in the Treatment of Leishmaniasis?

Infectious Disorders - Drug Targets, 13(5): 328-329.

Author(s): Nooshin Bagherani.

Affiliation: Dr. Nooshin Bagherni's Office, Second Floor, Taha Physicians' Building, 40-meter Street, Khoramshahr, Khuzestan Province, Iran.


Leishmaniasis is a parasitic disease caused by Leishmania, transmitted by the bite of some sandfly species. It is endemic in 88 countries throughout the world. Pentavalent antimonials are the standard therapy for leismaniasis. Saffron (crocus sativus) belongs to the iridaceae family. This paper will outline the benefits and challenges of repurposing saffron for treating leishmaniasis.


Crocus sativus, cardiotoxicity, leishmaniasis, saffron, pathogenesis, treatment.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 13
Issue Number: 5
First Page: 328
Last Page: 329
Page Count: 2
DOI: 10.2174/1871526514666140217145454
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science